Does SOTAGLIFLOZIN Cause Off label use? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Off label use have been filed in association with SOTAGLIFLOZIN (INPEFA). This represents 5.1% of all adverse event reports for SOTAGLIFLOZIN.
24
Reports of Off label use with SOTAGLIFLOZIN
5.1%
of all SOTAGLIFLOZIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From SOTAGLIFLOZIN?
Of the 24 reports, 1 (4.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTAGLIFLOZIN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does SOTAGLIFLOZIN Cause?
Dizziness (51)
Diarrhoea (45)
Therapy interrupted (28)
Death (24)
Dyspnoea (22)
Headache (21)
Urinary tract infection (21)
Product use issue (20)
Nausea (18)
Fungal infection (16)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SOTAGLIFLOZIN Alternatives Have Lower Off label use Risk?
SOTAGLIFLOZIN vs SOTALOL
SOTAGLIFLOZIN vs SOTATERCEPT
SOTAGLIFLOZIN vs SOTATERCEPT-CSRK
SOTAGLIFLOZIN vs SOTORASIB
SOTAGLIFLOZIN vs SOTROVIMAB